TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs January 28, 2005
TCL Archive DCCP Funds 57 Percent Of Epidemiology R01a In FY 1981, Less In 1982 But Still Above The Average For All NCI October 2, 1981
